Contact
      Please use this form to send email to PR contact of this press release:
      
      Hagens Berman Advises Horizon Pharma (NASDAQ: HZNP) Investors of May 9, 2016 Lead Plaintiff Deadline in a Newly Filed Class Action
    
      TO:
      
      
      
      
      
      
      
    
      Please use this form to send email to PR contact of this press release:
      
      Hagens Berman Advises Horizon Pharma (NASDAQ: HZNP) Investors of May 9, 2016 Lead Plaintiff Deadline in a Newly Filed Class Action
    
      TO: